# Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

> **NCT04338867** · PHASE2 · COMPLETED · sponsor: **Instituto Nacional de Cancerologia de Mexico** · enrollment: 96 (actual)

## Conditions studied

- Phase II Clinical Trial
- Ninety-six Histologically Confirmed NSCLC Patients With BM
- Randomized 1:1 to Received TN Plus WBR or Only WBR
- ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

## Interventions

- **RADIATION:** Whole-brain radiotherapy

## Key facts

- **NCT ID:** NCT04338867
- **Lead sponsor:** Instituto Nacional de Cancerologia de Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2020-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04338867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04338867, "Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04338867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*